Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR2T12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | WDR61 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | PFDN2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | EIF3L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | TRMT1L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | B3GNTL1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | GYG1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | RMND5B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | CFAP58 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | NANS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |